Centene Corp banner

Centene Corp
NYSE:CNC

Watchlist Manager
Centene Corp Logo
Centene Corp
NYSE:CNC
Watchlist
Price: 37.995 USD -1.21% Market Closed
Market Cap: $18.7B

Centene Corp
Investor Relations

Centene Corporation, a titan in the managed care industry, orchestrates its operations with a focus on government-sponsored healthcare programs. Founded in 1984, Centene swiftly carved its niche by administering Medicaid services, a vital safety net for low-income individuals and families in the United States. The company adeptly navigates the complexities of healthcare delivery by partnering with state governments to provide managed healthcare services, ensuring access to quality care while keeping costs in check. Centene's growth strategy hinges on its expansive network, tailored to meet diverse health needs, including those of the medically underserved. Through strategic acquisitions, such as the pivotal purchase of WellCare Health Plans, Centene has bolstered its market position, broadening its reach across all 50 states.

Profiting primarily through capitation arrangements, Centene receives a fixed amount per member from the government in exchange for providing healthcare services. This model incentivizes efficiency and cost containment, as the company retains any cost savings generated. Beyond Medicaid, Centene has diversified its portfolio by delving into Medicare Advantage, Marketplace insurance plans, and international markets, thus ensuring resilience against fluctuations in any single segment. The company's revenue engine is fueled by its ability to strike a balance between quality healthcare delivery and disciplined fiscal management, driven by an insightful understanding of regional healthcare needs and regulatory landscapes. Through this model, Centene not only generates substantial revenue but also strives to positively impact health outcomes, exemplifying its commitment to a mission-driven approach in the ever-evolving healthcare ecosystem.

Show more
Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Last Earnings Call
Fiscal Period
Q4 2025
Call Date
Feb 6, 2026
AI Summary
Q4 2025

2025 Results: Centene reported full-year adjusted diluted EPS of $2.08, with Q4 results slightly ahead of expectations outlined in the prior quarter.

2026 Outlook: Management expects significant margin improvement and adjusted EPS greater than $3 for 2026, representing more than 40% year-over-year growth.

Medicaid Progress: Medicaid profitability improved in the back half of 2025, with the health benefits ratio (HBR) dropping to 93.0% in Q4 and management expecting stable margins for 2026.

Marketplace Recovery: Fundamental medical cost trends in the Marketplace segment were slightly better than expected; actions taken in late 2025 are expected to drive meaningful margin expansion in 2026.

Medicare Segment: Medicare Advantage performance met expectations, with a focus on reaching breakeven in 2027; Part D (PDP) saw strong revenue growth and solid margins.

Guidance Details: 2026 revenue is guided between $170B and $174B, with consolidated HBR expected to improve by 60 bps at the midpoint compared to 2025.

Operational Levers: Management highlighted aggressive cost management, fraud reduction, and strategic network optimization as drivers of improved performance.

Capital & Liquidity: Continued debt paydown and disciplined SG&A management supported financial stability.

Key Financials
Adjusted Diluted EPS
$2.08
GAAP Diluted Loss Per Share (Q4)
-$2.24
Premium and Service Revenue (2025)
$174.6B
Health Benefits Ratio (HBR, Q4 Medicaid)
93.0%
Consolidated Health Benefits Ratio (2026 Guidance)
90.9% to 91.7%
SG&A Expense Ratio (Q4)
7.5%
SG&A Expense Ratio (Full Year 2025)
7.4%
Debt Reduction (Q4)
$189M
Debt-to-Capital Ratio
46.5%
Medical Claims Liability
$20.5B
Days in Claims Payable
46 days
Medicaid Membership (End of 2025)
12.5M
Marketplace Membership (Q1 2026 Estimate)
3.5M
Medicare Membership (Post Open Enrollment)
8.7M
Part D (PDP) Membership
About 8.7M (expected end of Q1 2026)
Composite Medicaid Rate Adjustment (2025)
5.5% above 2024 levels
Marketplace Price Increase (2026)
30%
Other Earnings Calls

Management

Ms. Sarah M. London
CEO & Director
No Bio Available
Mr. Kenneth John Fasola
President
No Bio Available
Mr. Andrew Lynn Asher
Executive VP & CFO
No Bio Available
Mr. Christopher Andrew Koster
Executive VP, General Counsel & Secretary
No Bio Available
Mr. David P. Thomas
CEO of Markets & Medicaid
No Bio Available
Ms. Susan R. Smith
Chief Operating Officer
No Bio Available
Ms. Katie Nicole Casso
Senior VP, Chief Accounting Officer & Corporate Controller
No Bio Available
Mr. Brian Phillip LeClaire M.B.A., Ph.D.
Chief Information Officer
No Bio Available
Ms. Jennifer Lynch Gilligan
Senior Vice President of Investor Relations
No Bio Available
Ms. Ashlee Knuckey
Chief Risk, Ethics & Compliance Officer
No Bio Available

Contacts

Address
MISSOURI
St. Louis
7700 Forsyth Blvd
Contacts
+13147254477.0
www.centene.com